Phase 1/2 Study of HS-10370 in Patients with Advanced Solid Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

176

Participants

Timeline

Start Date

June 3, 2022

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2026

Conditions

Advanced Solid Tumor

Interventions

DRUG

HS-10370

HS-10370 will be administered orally once daily in a continuous regimen

Trial Locations (1)

RECRUITING

Union Hospital Tong Ji Medical College, HuaZhong University of Science and Technology, Wuhan